Sanne L Nijhof1, Juliette M T M Rutten2, Cuno S P M Uiterwaal3, Gijs Bleijenberg4, Jan L L Kimpen5, Elise M van de Putte6. 1. Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands. Electronic address: s.l.nijhof@umcutrecht.nl. 2. Department of Paediatrics, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands. Electronic address: j.m.rutten@amc.uva.nl. 3. Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands. Electronic address: c.s.p.m.uiterwaal@umcutrecht.nl. 4. Expert Centre for Chronic Fatigue, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: G.Bleijenberg@nkcv.umcn.nl. 5. Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands. Electronic address: j.kimpen@umcutrecht.nl. 6. Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands. Electronic address: e.vandeputte@umcutrecht.nl.
Abstract
BACKGROUND: There is accumulating evidence of hypothalamic-pituitary-adrenal (HPA) axis hypofunction in chronic fatigue syndrome (CFS). However, knowledge of this hypofunction has so far come exclusively from research in adulthood, and its clinical significance remains unclear. The objective of the current study was to assess the role of the HPA-axis in adolescent CFS and recovery from adolescent CFS. METHOD: Before treatment, we compared the salivary cortisol awakening response of 108 diagnosed adolescent CFS patients with that of a reference group of 38 healthy peers. Salivary cortisol awakening response was measured again after 6 months of treatment in CFS patients. RESULTS: Pre-treatment salivary cortisol levels were significantly lower in CFS-patients than in healthy controls. After treatment recovered patients had a significant rise in salivary cortisol output attaining normalization, whereas non-recovered patients improved slightly, but not significantly. The hypocortisolism found in CFS-patients was significantly correlated to the amount of sleep. Logistic regression analysis showed that an increase of one standard deviation in the difference between pre- and post-treatment salivary cortisol awakening response was associated with a 93% higher odds of recovery (adjusted OR 1.93 (1.18 to 3.17), p=0.009). Pre-treatment salivary cortisol did not predict recovery. CONCLUSIONS: Hypocortisolism is associated with adolescent CFS. It is not pre-treatment cortisol but its change to normalization that is associated with treatment success. We suggest that this finding may have clinical implications regarding the adaptation of future treatment strategies.
BACKGROUND: There is accumulating evidence of hypothalamic-pituitary-adrenal (HPA) axis hypofunction in chronic fatigue syndrome (CFS). However, knowledge of this hypofunction has so far come exclusively from research in adulthood, and its clinical significance remains unclear. The objective of the current study was to assess the role of the HPA-axis in adolescent CFS and recovery from adolescent CFS. METHOD: Before treatment, we compared the salivary cortisol awakening response of 108 diagnosed adolescent CFS patients with that of a reference group of 38 healthy peers. Salivary cortisol awakening response was measured again after 6 months of treatment in CFS patients. RESULTS: Pre-treatment salivary cortisol levels were significantly lower in CFS-patients than in healthy controls. After treatment recovered patients had a significant rise in salivary cortisol output attaining normalization, whereas non-recovered patients improved slightly, but not significantly. The hypocortisolism found in CFS-patients was significantly correlated to the amount of sleep. Logistic regression analysis showed that an increase of one standard deviation in the difference between pre- and post-treatment salivary cortisol awakening response was associated with a 93% higher odds of recovery (adjusted OR 1.93 (1.18 to 3.17), p=0.009). Pre-treatment salivary cortisol did not predict recovery. CONCLUSIONS: Hypocortisolism is associated with adolescent CFS. It is not pre-treatment cortisol but its change to normalization that is associated with treatment success. We suggest that this finding may have clinical implications regarding the adaptation of future treatment strategies.
Authors: Fred H Bess; Samantha J Gustafson; Blythe A Corbett; E Warren Lambert; Stephen M Camarata; Benjamin W Y Hornsby Journal: Ear Hear Date: 2016 May-Jun Impact factor: 3.570
Authors: Marilyn N Vera-Chang; Antony D St-Jacques; Rémi Gagné; Chris J Martyniuk; Carole L Yauk; Thomas W Moon; Vance L Trudeau Journal: Proc Natl Acad Sci U S A Date: 2018-12-10 Impact factor: 11.205
Authors: Daniel L Hall; Emily G Lattie; Michael H Antoni; Mary Ann Fletcher; Sara Czaja; Dolores Perdomo; Nancy G Klimas Journal: Psychoneuroendocrinology Date: 2014-07-06 Impact factor: 4.905
Authors: Marieke E van Der Schaaf; Iris C Schmits; Megan Roerink; Dirk E M Geurts; Ivan Toni; Karin Roelofs; Floris P De Lange; Urs M Nater; Jos W M van der Meer; Hans Knoop Journal: BMC Psychiatry Date: 2015-07-03 Impact factor: 3.630
Authors: Peter C Rowe; Rosemary A Underhill; Kenneth J Friedman; Alan Gurwitt; Marvin S Medow; Malcolm S Schwartz; Nigel Speight; Julian M Stewart; Rosamund Vallings; Katherine S Rowe Journal: Front Pediatr Date: 2017-06-19 Impact factor: 3.418